Two Types of Alzheimer's β-Amyloid (1-40) Peptide Membrane Interactions: Aggregation Preventing Transmembrane Anchoring Versus Accelerated Surface Fibril Formation

Journal of Molecular Biology

Volumn 335, Issue 4, 2004, Pages 1039-1049

  Bokvist, Marcus ^a   Lindström, Fredrick ^a   Watts, Anthony ^b   Gröbner, Gerhard ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Circular dichroism; Lipid membrane; Peptide insertion; amyloid peptide

Indexed keywords

AMINO ACID DERIVATIVE; AMYLOID BETA PROTEIN[1-40]; LIPID; LYSINE DERIVATIVE; MEMBRANE PROTEIN; PEPTIDE; UNCLASSIFIED DRUG;

ACIDITY; ALPHA HELIX; ALZHEIMER DISEASE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CIRCULAR DICHROISM; FIBER; HYDROPHOBICITY; MAGIC ANGLE SPINNING NUCLEAR MAGNETIC RESONANCE; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; MOLECULAR MECHANICS; NERVE MEMBRANE; NEUROTOXICITY; NUCLEAR MAGNETIC RESONANCE; OLIGOMERIZATION; PATHOPHYSIOLOGY; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ASSEMBLY; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN INTERACTION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; PROTEIN STABILITY; SPECTROSCOPY;

INSERTION SEQUENCES;

EID: 0347753786     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2003.11.046     Document Type: Article

References (52)

1. Masters C.L., Simms G., Weinman N.A., Multhaup G., McDonald B.L., Beyreuther K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl Sci. USA. 82:1985;4245-4249.
2. Haass C., Selkoe D.J. Cellular processing of β-amyloid precursor peptide and the genesis of amyloid beta-peptide. Cell. 75:1993;1039-1042.
3. Iversen L.L., Mortishire-Smith R.J., Pollack S.J., Shearman M.S. The toxicity in vitro of β-amyloid peptide. Biochem. J. 311:1995;1-16.
4. Rochet J.-C., Lansbury P.T. Jr. Amyloid fibrillogenesis: themes and variations. Curr. Opin. Struct. Biol. 10:2000;60-68.
5. Bucciantini M., Giannoni E., Chiti F., Baroni F., Formigli L., Zurdo J., et al. Inherent toxicity of aggregates implies a common mechanism for peptide misfolding diseases. Nature. 416:2002;507-511.
6. Lansbury T.P. Jr. Evolution of amyloid: what normal peptide folding may tell us about fibrillogenesis and disease. Proc. Natl Acad. Sci. USA. 96:1999;3342-3344.
7. Walsh D.M., Hartley D.M., Kusumoto Y., Fezoui Y., Condron M.M., Lomakin A., et al. Amyloid β-peptide fibrillogenesis. Structure and biological activity of protofibrillar intermediates. J. Biol. Chem. 274:1999;25945-25952.
8. Walsh D., Tseng B.P., Rydel R.E., Podlisny M.B., Selkoe D.J. The oligomerization of amyloid β-peptide begins intracellularly in cells derived from human brain. Biochemistry. 39:2000;10831-10839.
9. Kirkitadze M.D., Condron M.M., Teplow D.B. Identification and characterization of key kinetic intermediates in amyloid-β-protein fibrillogenesis. J. Mol. Biol. 312:2001;1103-1119.
10. Kayed R., Head E., Thompson J.L., McIntire T.M., Milton S.C., Cotman C.W., Glabe C. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science. 300:2003;486-489.
11. De Strooper B., König G. Alzheimer's disease - an inflammatory drug prospect. Nature. 414:2001;159-160.
12. Lorenzo A., Yuan M., Zhang Z., Paganetti P.A., Sturchler-Pierrat C., Staufenbiel M.A., et al. Amyloid β interacts with the amyloid precursor peptide: a potential toxic mechanism in Alzheimer's disease. Nature Neurosci. 3:2000;460-464.
13. Yuan J., Yankner B.A. Apoptosis in the nervous system. Nature. 407:2000;802-809.
14. Sawamura N., Morishima-Kawashima M., Waki H., Kobayashi K., Kuramochi T., Frosch M.P., et al. Mutant-presenilin 2-transgenic mice - a large increase in the levels of Aβ-42 is presumably associated with the low-density membrane domain that contains decreased levels of glycerophospholipids and sphingomyelin. J. Biol. Chem. 275:2000;27901-27908.
15. Simons M., Keller P., De Strooper B., Beyreuther K., Dotti C.G., Kimons K. Cholesterol depletion inhibits the generation of β-amyloid in hippocampal neurons. Proc. Natl Acad. Sci. USA. 95:1998;6460-6464.
16. Ji S.-R., Wu Y., Sui S. Cholesterol is an important factor affecting the membrane insertion of β-amyloid peptide (Aβ 1-40), which may potentially inhibit the fibril formation. J. Biol. Chem. 277:2002;6273-6279.
17. Pettegrew J.W., Panchalingam K., Hamilton R.L., McClure R.J. Brain membrane phospholipid alterations in Alzheimer's disease. Neurochem. Res. 26:2001;771-782.
18. Kracun I., Kalanj S., Cosovic C., Talanhranilovic J., Cosovic C. Cortial distribution of gangliosides in Alzheimers-disease. Neurochem. Int. 20:1992;433-438.
19. Waschuk S.A., Elton E.A., Darabie A.A., Fraser P.E., McLaurin J. Cellular membrane composition defines Aβ-lipid interactions. J. Biol. Chem. 276:2001;33561-33568.
20. Mason R.P., Jacob R.F., Walter M.F., Mason P.E., Avdulov N.A., Chochina S.V., et al. Distribution and fluidizing action of soluble and aggregated amyloid β-peptide in rat synaptic plasma membranes. J. Biol. Chem. 274:1999;18801-18807.
21. Kremer J.J., Pallitto M.M., Sklansky D.J., Murphy R.M. Correlation of β-amyloid aggregate size and hydrophobicity with decreased bilayer fluidity of model membranes. Biochemistry. 39:2000;10309-10318.
22. Yip C.M., McLaurin J. Amyloid-beta peptide assembly: a critical step in fibrillogenesis and membrane disruption. Biophys. J. 80:2001;1359-1371.
23. Kawahara M., Kuroda Y., Arispe N., Rojas E. Alzheimer's β-amyloid, human islet amylin, and prion peptide fragment evoke intracellular free calcium elevations by a common mechanism in a hypothalamic GnRH neuronal cell line. J. Biol. Chem. 275:2000;14077-14083.
24. Demmester N., Baier G., Enzinger C., Goethals M., Vandekerckhove J., Rosseneu M., Labeur C. Apoptosis induced in neuronal cells by C-terminal amyloid β-fragments is correlated with their aggregation properties in phospholipid membranes. Mol. Membr. Biol. 17:2000;219-228.
25. Lin H., Bhatia R., Lal R. Amyloid β protein forms ion channels: implications for Alzheimer's disease pathology. FASEB J. 15:2001;2433-2444.
26. Koppaka V., Axelsen P.H. Accelerated accumulation of amyloid β peptides on oxidatively damaged lipid membranes. Biochemistry. 39:2000;10011-10016.
27. McLaurin J., Yang D.-S., Yip C.M., Fraser P.E. Review: modulating factors in amyloid-β fibril formation. J. Struct. Biol. 130:2000;259-270.
28. Terzi E., Hölzemann G., Seelig J. Interaction of Alzheimer β-amyloid peptide(1-40) with lipid membranes. Biochemistry. 36:1997;14845-14852.
29. Yip M.C., Darabie A.A., McLaurin J. Aβ42-peptide assembly on lipid bilayers. J. Mol. Biol. 318:2002;97-107.
30. Choo-Smith L.-P., Garzon-Rodriguez W., Glabe C.G., Surewicz W.K. Acceleration of amyloid fibril formation by specific binding of A beta-(1-40) peptide to ganglioside-containing membrane vesicles. J. Biol. Chem. 272:1997;22987-22990.
31. Kakio A., Nishimoto S., Yanagisawa K., Kozutsumi Y., Matsuzaki K. Interactions of amyloid β-peptide with various gangliosides in raft-like membranes: Importance of GM1 ganglioside-bound form as an endogenous seed for Alzheimer amyloid. Biochemistry. 41:2002;7385-7390.
32. McLaurin J., Chakrabartty A. Characterization of the interactions of Alzheimer β-amyloid peptides with phospholipid membranes. Eur. J. Biochem. 245:1997;355-363.
33. Gröbner G., Glaubitz C., Williamson P.T.F., Hadingham T., Watts A. Structural insight into the interaction of amyloid-β peptide with biological membranes by solid state NMR. Kiihne S.R., deGroot H.J.M. Perspectives on Solid State NMR in Biology. 2001;203-214 Kluwer Academic Publishers, Dordrecht.
34. Gibson Wood W., Eckert G.P., Igbavboa U., Müller W.E. Amyloid beta-protein interactions with membranes and cholesterol: causes or casualties of Alzheimer's disease. Biochim. Biophys. Acta. 1610:2003;281-290.
35. Wang S.S.-S., Rymer D.L., Good T.A. Reduction in cholesterol and sialic acid content protects cells from the toxic effects of β-amyloid peptides. J. Biol. Chem. 276:2001;42027-42034.
36. Curtain C.C., Ali F.E., Smith D.G., Bush A.I., Masters C.L., Barnham K.J. Metal ions, pH, and cholesterol regulate the interactions of Alzheimer's disease amyloid-β peptide with membrane lipid. J. Biol. Chem. 278:2003;2977-2982.
37. Dufourc E.J., Mayer C., Stohrer J., Althoff G., Kothe G. Dynamics of phosphate head groups in biomembranes. Biophys. J. 61:1992;42-57.
38. Bonev B., Watts A., Bokvist M., Gröbner G. Electrostatic peptide-lipid interactions of amyloid-beta peptide and pentalysine with membrane surfaces monitored by P-31 MAS NMR. Phys. Chem. Chem. Phys. 3:2001;2904-2910.
39. Carbone M.A., Macdonald P.M. Cardiotoxin II segregates phosphatidylglycerol from mixtures with phosphatidylcholine: P-31 and H-2 NMR spectroscopic evidence. Biochemistry. 35:1996;3368-3378.
40. Pinheiro T.J.T., Watts A. Resolution of individual lipids in mixed phospholipid-membranes and specific lipid cytochrome-C interactions by magic-angle-spinning solid-state P-31 NMR. Biochemistry. 33:1994;2459-2467.
41. Lindström F., Bokvist M., Sparrman T., Gröbner G. Association of amyloid-beta peptide with membrane surfaces monitored by solid state NMR. Phys. Chem. Chem. Phys. 4:2002;5524-5530.
42. Murray D., Arbuzova A., Hangyas-Mihalyne G., Gambhir A., Ben-Tal N., Honig B. Electrostatic properties of membranes containing acidic lipids and adsorbed basic peptides: theory and experiment. Biophys. J. 77:1999;3176-3188.
43. Sreerama N., Venyaminov S.Y., Woody R.W. Estimation of peptide secondary structure from circular dichroism spectra: inclusion of denatured peptides with native peptides in the analysis. Anal. Biochem. 287:2000;243-251.
44. Sreerama N., Woody R.W. Estimation of peptide secondary structure from circular dichroism spectra: comparison of CONTIN, SELCON, and CDSSTR methods with an expanded reference set. Anal. Biochem. 287:2000;252-260.
45. Coles M., Bicknell W., Watson A.A., Fairlie D.P., Craik D.J. Solution structure of amyloid beta-peptide(1-40) in a water-micelle environment. Is the membrane-spanning domain where we think it is? Biochemistry. 37:1998;11064-11077.
46. Sticht H., Bayer P., Willbold D., Dames S., Hilbich C., Beyreuther K., et al. Structure of amyloid A4-(1-40)-peptide of Alzheimers-disease. Eur. J. Biochem. 233:1995;293-298.
47. Terzi E., Hölzemann G., Seelig A. Self-association of beta-amyloid peptide(1-40) in solution and binding to lipid-membranes. J. Mol. Biol. 633:1995;642.
48. Sixl F., Brophy P.J., Watts A. Selective protein-lipid interactions at membrane surfaces: a deuterium and phosphorus nuclear magnetic resonance study of the association of myelin basic protein with the bilayer head groups of dimyristoylphosphatidylcholine and dimyristoylphosphatidylglycerol. Biochemistry. 23:1984;2032-2039.
49. Sixl F., Watts A. Deuterium and phosphorus nuclear-magnetic-resonance studies on the binding of polymyxin-B to lipid bilayer water interfaces. Biochemistry. 24:1985;7906-7910.
50. Matsuzaki K., Horikiri C. Interactions of amyloid β-peptide (1-40) with ganglioside-containing membranes. Biochemistry. 38:2000;4137-4142.
51. T1. Biophys. J. 49:1986;741-752.
52. Strandberg E., Morein S., Rijkers D.T.S., Liskamp R.M.J., van der Wel P.C.A., Killian J.A. Lipid dependence of membrane anchoring properties and snorkeling behavior of aromatic and charged residues in transmembrane peptides. Biochemistry. 41:2002;7190-7198.